Your browser doesn't support javascript.
loading
Combined loss of TFF3 and PTEN is associated with lethal outcome and overall survival in men with prostate cancer.
Abou-Ouf, Hatem; Ghosh, Sunita; Box, Adrian; Palanisamy, Nallasivam; Bismar, Tarek A.
Affiliation
  • Abou-Ouf H; Department of Pathology and Laboratory Medicine, University of Calgary Cumming School of Medicine and Calgary Laboratory Services, Calgary, AB, Canada.
  • Ghosh S; Department of Medical Oncology, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, AB, Canada.
  • Box A; Department of Pathology and Laboratory Medicine, University of Calgary Cumming School of Medicine and Calgary Laboratory Services, Calgary, AB, Canada.
  • Palanisamy N; Department of Urology, Vattikuti Urology Institute, Henry Ford Health System Detroit, Detroit, MI, USA.
  • Bismar TA; Department of Pathology and Laboratory Medicine, University of Calgary Cumming School of Medicine and Calgary Laboratory Services, Calgary, AB, Canada. tabismar@ucalgary.ca.
J Cancer Res Clin Oncol ; 145(7): 1751-1759, 2019 Jul.
Article in En | MEDLINE | ID: mdl-31129769
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms / PTEN Phosphohydrolase / Trefoil Factor-3 Type of study: Prognostic_studies / Risk_factors_studies Limits: Humans / Male Language: En Journal: J Cancer Res Clin Oncol Year: 2019 Document type: Article Affiliation country: Canada Country of publication: Germany
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms / PTEN Phosphohydrolase / Trefoil Factor-3 Type of study: Prognostic_studies / Risk_factors_studies Limits: Humans / Male Language: En Journal: J Cancer Res Clin Oncol Year: 2019 Document type: Article Affiliation country: Canada Country of publication: Germany